Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.
The majority of natural history studies of human immunodeficiency virus (HIV) infection have immune and viral parameters in men. Data demonstrating that women have lower HIV-1 RNA levels than men at the same CD4 cell counts have raised the question of immunologic differences in HIV-seropositive women. This study describes levels and changes in phenotypic markers of immune maturity, function, and activation in the CD4 and CD8 cell subsets in HIV-seropositive and high-risk HIV-seronegative women. Our primary hypothesis was that activation levels would be significantly higher among illicit drug users. However, results showed that HIV-1 RNA level was the strongest predictor of marker level and that both HIV-1 RNA level and CD4 cell count were independently associated with CD4 activation, but illicit drug use was not. In summary, this study demonstrated that immune activation was a significant pathogenic feature in women and that activation was driven by HIV infection and not illicit drug use.
Landay
Alan
A
Department of Immunology/Microbiology, Rush Medical College, 1735 W. Harrison Street, Rm. 616 Cohn, Chicago, IL 60612, USA. alanday@rush.edu
Benning
Lorie
L
Bremer
James
J
Weiser
Barbara
B
Burger
Harold
H
Nowicki
Marek
M
Kovacs
Andrea
A
D015415:Biomarkers / Q000097:blood*; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008213:Lymphocyte Activation; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D012737:Sex Factors; D019966:Substance-Related Disorders / Q000097:blood / Q000276:immunology*
D015415:Biomarkers; D012367:RNA, Viral